In a year with modest economic growth, it was consolidations, divestments and growing technology bases that were some of the factors that altered rankings among IBO’s list of the top 30 analytical and life science instrument and aftermarket companies for 2012. Among the list’s most notable changes was Illumina’s entry into the top 10 due […]
An American College of Medical Genetics and Genomics (ACMG) working group recommended this month that patients whose genomes are sequenced for a medical condition be told whether they have a predisposition to other diseases. The recommendations, the first from a professional society about how to handle so-called “incidental findings,” apply to all children and adults, […]
The total hectarage of biotech crops increased 6.2% to 170.3 million hectares in 2012. The hectarage of stacked-trait biotech crops grew 3.6% last year to comprise 26% of the global biotech area. Biotech crops were grown in 28 countries, led by the US, Brazil and Argentina, where biotech crop production accounted for 41%, 21% and […]
The FDA has proposed changes to its approval process for new Alzheimer’s drugs, which is expected to ease approval by providing clearer criteria. Published on the website of The New England Journal of Medicine, the plan would eliminate the requirement that a clinical trial show improvement in patients’ daily functioning. Rather, improvement in early-stage Alzheimer’s […]
For the first time in its 63-year history, the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy was held in Philadelphia, Pennsylvania, marking a welcome return to the Northeast US, which many vendors hoped would boost attendance. The conference took place March 17–30. It appears the new location did help. Organizers told IBO that preliminary […]
A survey by Chemical & Engineering News (C&EN) finds that 10 chemical companies plan to increase their combined R&D spending 3.6% this year to $7.4 billion, following a 7.8% increase in 2012. Only one of the 10 firms plans to decrease R&D expenditures. Eighteen companies surveyed plan to increase expenditures for plants and equipment by […]
Biosimilar drugs are proving more difficult to produce than originally anticipated in some cases. Merck & Co., Samsung and Teva Pharmaceutical Industries are among the companies that have recently faced delays in the development of biosimilars. Reasons for the setbacks include complications in creating biologics, new patents on the original drugs or their manufacturing processes, […]
On February 15, the US Department of Justice and the National Institute of Standards and Technology (NIST) announced plans for the National Commission on Forensic Science initiative, which will address quality issues regarding forensic evidence used in criminal cases. The Commission will develop proposals for the US attorney general and Department of Justice and will […]
Multi-vendor laboratory services have proved to be a fast growing and strategic market for analytical instrument companies. Such services not only expand a particular instrument company’s share of an end-user’s service revenues, but also provide greater customer intimacy and an expanded presence in the end-user’s lab. As a result, the breadth of such offerings has […]
Starting this year, the US Centers for Medicare and Medicaid Services (CMS) has instituted a new system for Common Procedural Terminology codes, which are used to bill Medicare for molecular diagnostics tests. Test 1 tests include most of the tests already in use. Tier 2 consists of low-volume, esoteric test divided among nine levels. Pricing […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
